Position
Chief Commercial Officer
Company
Neurogene
New YorkOtherBiotechnologyHealth CareTherapeuticsDescription
Neurogene announces the appointment of Christy Shafer as Chief Commercial Officer to lead its commercial strategy for the NGN-401 gene therapy. This hiring strengthens Neurogene's executive team as it prepares for significant growth in advancing its neurology-focused therapies.
Quick answer
Neurogene Appoints Christy Shafer as Chief Commercial Officer (April 20, 2026). Neurogene is based in New York, New York, United States.
- Who is the new Chief Commercial Officer at Neurogene?
- Neurogene named Christy Shafer Chief Commercial Officer, announced April 20, 2026.
- What did Neurogene announce on April 20, 2026?
- Neurogene announces the appointment of Christy Shafer as Chief Commercial Officer to lead its commercial strategy for the NGN-401 gene therapy. This hiring strengthens Neurogene's executive team as it prepares for significant growth in advancing its neurology-focused therapies.
- What does Neurogene do?
- Neurogene Inc. is a clinical-stage company dedicated to bringing life-changing genetic medicines to patients and families affected by rare neurological diseases.
- Where is Neurogene based?
- Neurogene is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Modulari-T Biosciences (April 21, 2026), BPGbio (April 21, 2026), Paratus Sciences Corporation (April 22, 2026) and BridgeBio Oncology Therapeutics (April 22, 2026) also announced leadership changes within 45 days of Neurogene.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Modulari-T Biosciences Appoints Tanya E. Borsuk, PhD, as Chief Executive Officer (April 21, 2026)
- BPGbio Appoints Chas Bountra as Executive Vice President and Chief Science Officer (April 21, 2026)
- Paratus Sciences Appoints Alicia Secor as Chief Executive Officer and Jeffrey Young as Chief Financial Officer (April 22, 2026)
- BridgeBio Oncology Therapeutics Appoints Pedro J. Beltran as CEO and Idan Elmelech as COO (April 22, 2026)
- Jade Biosciences Appoints Edward R. Conner, M.D. as Chief Medical Officer (April 23, 2026)
- Stanislaw R. Burzynski appointed as CFO and Secretary (April 23, 2026)
Who to call at Neurogene, and when
A new leader at Neurogene brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Neurogene raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurogene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurogene. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurogene changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Neurogene changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.